Shared on04 Aug 25Fair value Decreased 13%
The downward revision in Select Medical Holdings’ price target reflects a significant decline in net profit margin and a higher discount rate, resulting in a new consensus fair value of $18.33 per share. What's in the News Repurchased 5,725,708 shares for $85.04 million, completing a total buyback of 54,610,335 shares for $697.07 million under the ongoing program.
Shared on30 Apr 25Fair value Increased 0.99%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Increased 1.62%
AnalystConsensusTarget has increased future PE multiple from 14.8x to 16.7x.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 0.97%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on11 Mar 25Fair value Increased 10%
AnalystConsensusTarget has decreased revenue growth from -2.7% to 6.5%, increased profit margin from 2.4% to 3.8% and decreased future PE multiple from 45.0x to 14.7x.